Skip to main content
ACRV logo

ACRV

Acrivon Therapeutics, Inc.
$1.78 +0.06 (+3.49%) At close · Jul 6
Market Cap
$76.19M
Shares
42,801,729

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 44
Total Value: $22,568,194
Total Shares: 16,236,130

Institutional Ownership Trend

14 quarters

Holder Concentration

Across 44 13F filers · Δ vs Dec 31, 2025
Top Holder
51.4%
Jun 2023 → Mar 2026 · range 28.8% – 51.4%
+6.6 pts
Top 5
79.8%
Jun 2023 → Mar 2026 · range 73.6% – 82.8%
+6.2 pts
Top 10
93.0%
Jun 2023 → Mar 2026 · range 88.1% – 94.9%
+4.9 pts
HHI
2,935
Jun 2023 → Mar 2026 · range 1,535 – 2,935
Highly concentrated+625

Quarterly Activity

vs Dec 31, 2025
New
10
Increased
11
Decreased
11
Sold Out
14
Unchanged
12
Holder count: -4
Institutional value: -49.7%
Shares held: -12.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 44 of 44
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1781174 CUSIP 004890109 Visit website Investor relations